期刊文献+

三化汤对脑缺血再灌注大鼠脑组织基质金属蛋白酶-9表达的影响 被引量:10

The Effect of Sanhua Tang on Expression of MMP-9 of Brain Tissues in Cerebral Ischemia-reperfusion Rat
原文传递
导出
摘要 目的:观察三化汤对脑缺血再灌注大鼠脑组织基质金属蛋白酶-9(MMP-9),MMP-9 mRNA表达的影响。方法:将大鼠随机分为假手术组、模型组、三化汤低、高剂量组(7.2,14.4 g.kg-1)ig、尼莫地平组(8.1 mg.kg-1)ig。大鼠常规饲养3d后ig给药,每日1次,连续给药7 d后采用线栓法制备脑缺血再灌注大鼠模型。采用免疫组织化学法检测各组大鼠脑组织MMP-9的表达,采用逆转录聚式酶链反应法(RT-PCR)检测脑组织MMP-9 mRNA的表达。结果:模型组脑组织MMP-9,MMP-9mRNA表达显著升高(P<0.01);三化汤高剂量组脑组织MMP-9,MMP-9 mRNA表达显著降低(P<0.01),尼莫地平组脑组织MMP-9,MMP-9 mRNA表达也明显降低(P<0.05),三化汤低剂量组脑组织MMP-9,MMP-9 mRNA表达降低不明显;三化汤高剂量组降低脑组织MMP-9,MMP-9 mRNA表达较尼莫地平组明显。结论:三化汤对大鼠脑缺血再灌注损伤具有一定的保护作用。 Objective: To observe the effect of Sanhua Tang on expression of MMP-9 in brain tissues of cerebral ischemia-reperfusion rat. Method: The rats were randomly allotted 5 groupa as following: sham operation group, model group, low dose group of Sanhua Tang (7.2 g . kg-1 ) , large dose group of Sanhua Tang ( 14.4 g .kg-1) ig, and nimodipine group (8.1 mg . kg-1) ig. After 3 days of routine breeding, Sanhua Tang was administered to rats by intragastric administration once every day for a week. The cerebral ischemia reperfusion model was reproduced by blocking middle cerebral arteryt with suture method. The expression of MMP-9 protein was detected by immunohistochemical methods with marketable kit, and mRNA expression of MMP-9 was assayed by RT-PCR. Result: In model group the expression of MMP-9 and MMP-9 mRNA in brain tissues was significantly increased (P 〈 0.01). In large dose group of Sanhua Tang the expression of MMP-9 and MMP-9 mRNA was significantly decreased (P 〈 0.01 ). In nimodipine group the expression of MMP-9 and MMP-9 mRNA was significantly decreased (P 〈 0.05). In low dose group of Sanhua Tang the expression of MMP-9, and MMP-9 mRNA was less significantly decreased. In large dose group of Sanhua Tang the expression of MMP-9, MMP-9 mRNA was decreased more significantly than in nimodipine group. Conclusion: The mechanism of Sanhua Tang protecting against injure of cerebral ischemia reperfusion may be involved in ameliorating MMP expression.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第6期210-214,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 山东省教育厅资助课题(J06L18)
关键词 三化汤 脑缺血再灌注 基质金属蛋白酶-9 MMP-9 mRNA Sanhua Tang cerebral ischemia-reperfusion MMP-9, MMP-9 mRNA
  • 相关文献

参考文献10

  • 1Fu jimura M,Gache Y,Moritar Fu jimura Y,et al.Early appearance of activated matrix metalloproteinase-9and blood brain barrier disrup-tion in mice after focalcerebral ischemia and reperfusion[J].Brain Res,1999,842(1):92.
  • 2毛玲,查运红,梅元武.基质金属蛋白酶-9与脑缺血血脑屏障损伤的关系[J].国际神经病学神经外科学杂志,2006,33(1):96-98. 被引量:23
  • 3Ihara M,Tomimoto H,Kinoshita M,et al.Chroniccerebral hypoperfusion induces MMP-2 but not MMP-9expression in the microglia and vascular endothelium ofwhite matter[J].Cereb Blood Flow Metab,2001,21:828.
  • 4Heo J H,Lucero J,Abumiya T,et al.Matrixmetalloproteinases increase very early duringexperimental focal cerebral ischemia[J]Cereb BloodFlow Metab,1999,19:624.
  • 5孟宜良.线栓法大鼠大脑中动脉局灶性脑缺血模型研究现状[J].国外医学(神经病学.神经外科学分册),2002,29(2):113-115. 被引量:45
  • 6Rosenberg G A,Estrada E Y,Dencoff J E.Matrixmetalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain[J].Stroke,1998,29(10):2189.
  • 7刘华,廖维靖,杨万同,郑婵娟,蒙兰青.脑缺血再灌注后基质金属蛋白酶-9的早期表达及对血脑屏障的破坏[J].中华物理医学与康复杂志,2004,26(4):203-205. 被引量:17
  • 8张毅,徐群,苏敏,苗玲,蔡琰.缺血性脑卒中患者急性期血浆中基质金属蛋白酶-9含量的动态变化[J].脑与神经疾病杂志,2003,11(4):226-227. 被引量:7
  • 9Gursoy-Ozdemir Y,Bolay H,Saribas O,et al.Role ofendothelialNO generation and peroxynitrite formation inreperfusion injuryafter focal cerebral ischemia[J].Stoke,2000,(31):1974.
  • 10Asahi M,Wang X Y,Mori T,et al.Effects of MatrixMetalloProteinase-9 Gene Knock-Out on the proteolysisof Blood-Brain Barrier and White Matter Componentsafter Cerebral ischemia[J].Neurosci,2004,21.

二级参考文献58

  • 1中华神经科学会.脑卒中患者临床神经功能损伤程度评分标准(1995).临床疗效评定标准[J].中华神经杂志,1996,29:381-381.
  • 2Seisio. Mechanisms of ischemic brain damage. Crit Care Med,1988,16:954~963.
  • 3Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma, 1995,12:833~842.
  • 4Rosenberg GA. Matrix metalloproteinases in neuroinflamation.Glia, 2002,39:279~291.
  • 5Rosenberg GA, Navratil M, Barone F, et al. J Cereb Blood Flow Metab, 1996,16:360~366.
  • 6Gasehe Y, Fujimura M, Morita-Rujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction,1999,19 : 1020~ 1028.
  • 7Asahi M, Asahi K, Jung JC, et al. J Cereb Blood Flow Metab,2000,20: 1681~ 1689.
  • 8Romanic AM, Raymond F, White BS, et al. Stroke, 1998, 29:1020~1030.
  • 9Mandal M, Mandal A, Das S, et al. Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003, 252 ( 1-2 ) :305 -329.
  • 10Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci, 2006, 11(1): 1696-1701.

共引文献87

同被引文献193

引证文献10

二级引证文献225

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部